To provide patients with optimal, individualized care, this enduring activity offers expert-guided education to US-based oncologists, pathologists, NPs, and PAs on the impact of biomarker testing on treatment plans and outcomes across various tumor types, as well as an understanding of how, when, and optimal strategies to implement biomarker testing in clinical practice. This educational accredited activity is developed with direct insights from the learner audience via survey feedback to provide focus on improving clinicians’ knowledge and competence in biomarker testing across various tumor types. As a result of this educational activity, learners should be better able to: 1. Recognize the impact of biomarker testing on patient outcomes across tumor types; 2. Identify optimal strategies for implementing biomarker testing in clinical practice; and, 3. Outline patient-centered strategies to optimize outcomes following identification of actionable biomarkers/mutations. Downloadable slides will also be available for clinical use in practice.
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/SWT
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Merck (Any division) - Amount: 179217.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all